Met Life Investment Management, LLC Eloxx Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.37 - $9.91 $62,941 - $142,733	-14,403 Closed	0 $0
Q2 2019 Jul 12, 2023	BUY	$8.77 - $12.49 $126,314 - $179,893	14,403 New	14,403 $143,000
Q1 2019 Jul 13, 2023	BUY	$10.45 - $13.94 $150,511 - $200,777	14,403 New	14,403 $168,000
Q4 2018 Jul 13, 2023	BUY	$10.43 - $17.39 $150,223 - $250,468	14,403 New	14,403 $172,000
Q4 2018 Mar 22, 2023	SELL	$10.43 - $17.39 $82,855 - $138,146	-7,944 Reduced 35.55%	14,403 $172,000
Q4 2018 Feb 14, 2019	SELL	$10.43 - $17.39 $82,855 - $138,146	-7,944 Reduced 35.55%	14,403 $173,000
Q3 2018 Jul 13, 2023	BUY	$11.95 - $19.63 $172,115 - $282,730	14,403 New	14,403 $245,000
Q3 2018 Mar 22, 2023	BUY	$11.95 - $19.63 $267,046 - $438,671	22,347 New	22,347 $380,000
Q3 2018 Nov 14, 2018	BUY	$11.95 - $19.63 $267,046 - $438,671	22,347 New	22,347 $381,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.